Allergic rhinitis – Asian Pacific Journal of Allergy and Immunology

November 28, 2024

Chronic rhinitis and its impact on COPD: A literature review

Chronic obstructive pulmonary disease (COPD) exerts a notable impact on the quality of life of individuals, precipitating substantial economic burdens. A probable association exists between chronic obstructive pulmonary disease (COPD) and chronic rhinitis (CR).

Allergic rhinitis, chronic obstructive pulmonary disease, chronic rhinitis, literature review, non-allergic rhinitis

November 28, 2024

Medication adherence, sensory attributes, and adverse effects of intranasal corticosteroids in allergic rhinitis patients: A systematic review and meta-analysis

Intranasal corticosteroid (INCS) remains the primary treatment for allergic rhinitis (AR). Understanding adherence, safety concerns and sensory preferences is crucial for optimal care.

adverse effects, Allergic rhinitis, intranasal corticosteroids, medication adherence, patient preference

January 14, 2024

Evaluation of adherence and attitudes of patientswith allergic rhinitis to nasal steroid treatment

Allergic rhinitis (AR) is defined as an inflammatory disease of the nose. Nasal corticosteroids (NCS) are one of the most effective drugs used in AR treatment.

Adherence, Allergic rhinitis, medication, Morisky scale

October 15, 2023

Meta-analysis and cost-effectiveness analysisof intranasal corticosteroid treatment in allergic rhinitiswith ocular symptoms

Intranasal corticosteroid (INCS) has a beneficial effect on ocular symptoms in allergic rhinitis (AR). To our knowledge, the cost-effectiveness of available INCS for AR with ocular symptoms is yet to be demonstrated.

Allergic rhinitis, cost-effectiveness, economic evaluation, intranasal corticosteroids, ocular symptom

June 11, 2023

Inhibitory effect of Zingiber cassumunar Roxb. (Phlai)on nasal cytokine productions and eosinophilic recruitment in patients with allergic rhinitis

Zingiber cassumunar Roxb. (Phlai) has been used for the treatment of allergies including allergic rhinitis (AR). Although the anti-histamine effects have been reported, assessment of nasal cytokine and eosinophil production had not been investigated.

Allergic rhinitis, Eosinophils, Phlai, Th2 cytokine, Zingiber cassumunar

April 23, 2023

The natural history of childhood-onset nonallergic rhinitis; a long-term follow-up study

Non-allergic rhinitis (NAR) is characterized by symptoms of nasal inflammation without allergic sensitization. The long-term outcome of NAR in children is poorly defined.

Allergic rhinitis, childhood-onset nonallergic rhinitis, Children, natural history, nonallergic rhinitis, Sensitization

April 23, 2023

Mucosal brushings for nasal specific IgE to predict house dust mite driven allergic rhinitis

Skin prick testing and serological identification of allergen specific immunoglobulin E (spIgE) are standard tests for allergic rhinitis but can only identify systemic responses. In contrast, nasal allergen challenge (NAC), directly assess localized nasal mucosal reactivity, but is time consuming. Identification of spIgE from nasal brushings (nasal spIgE) is an alternative technique.

Allergic rhinitis, house dust mite, local allergic rhinitis, nasal allergen challenge, nasal brushings, nasal specific IgE, non allergic rhinitis

April 17, 2023

Comorbidities & burden of disease in atopic dermatitis

Atopic dermatitis is associated with an increased frequency of other atopic & allergic manifestations, including asthma in 10% to 30% of cases depending on age, allergic rhinitis, food allergies, eosinophilic diseases, and allergic conjunctivitis. The comorbidities outside the atopic march are overall less frequent than in psoriasis.

Allergic rhinitis, Asthma, atopic dermatitis, Comorbidity, Mental Health, Vitiligo

January 23, 2023

Allergen immunotherapy for respiratory allergies in clinical practice: A comprehensive review

Allergen-specific immunotherapy (AIT) is the only treatment that modifies the underlying pathophysiology of IgE-mediated allergic diseases.

allergen, Allergic rhinitis, Allergy, Asthma, Immunotherapy

October 25, 2022

House dust mite allergen immunotherapy for monosensitized versus polysensitized patients with allergic rhinitis: A systematic review and meta-analysis

Most patients with allergic rhinitis are polysensitized. The efficacy of house dust mite (HDM) allergen immunotherapy (AIT) compared between monosensitized and polysensitized patients remains limited.

Allergen immunotherapy, Allergic rhinitis, effectiveness, efficacy, house dust mite, monosensitized, polysensitized, subcutaneous immunotherapy, Sublingual immunotherapy